NCT00004825View on ClinicalTrials.gov

Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 1998

Study Completion Date

May 31, 1998

Conditions
Hyperinsulinism
Interventions
DRUG

recombinant human insulin-like growth factor I

All Listed Sponsors
collaborator

Children's Hospital of Philadelphia

OTHER

lead

FDA Office of Orphan Products Development

FED

NCT00004825 - Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism | Biotech Hunter | Biotech Hunter